Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

Sentinel surveillance of injuries and poisonings associated with cocaine and other substance use: results from the Canadian Hospitals Injury Reporting and Prevention Program (CHIRPP)

This study examined a wide range of injuries and poisonings related to cocaine only and in combination with other substances in Canada using sentinel surveillance data captured by the electronic Ca

Original research | 2022

Stimulants, Hospitals, Overdose, Illegal drugs

National Polydrug Use Patterns among People Who Misuse Prescription Opioids and People Who Use Heroin. Results from the National Household Survey on Drug Use and Health

We defined, estimated, and analyzed national polysubstance use patterns among people who misuse opioids (PWMO).

Original research | 2022

About PWUD, Illegal drugs, Stimulants

Modafinil for the treatment of cocaine dependence

Modafinil was tested for efficacy in facilitating abstinence in cocaine-dependent patients, compared to placebo.

Original research | 2009

Stimulants, Illegal drugs, Outcomes

Psychostimulant Treatment of Cocaine Dependence

Lit review | 2012

Stimulants, About prescribers, Clinical guidance

‘Even though you hate everything that's going on, you know they are safer at home’: The role of Aboriginal and Torres Strait Islander families in methamphetamine use harm reduction and their own support needs

The support needs of family members of individuals using methamphetamine are poorly understood.

Original research | 2022

Wrap-around services, Equity, Indigenous, Rural/remote, Stimulants

Signals of increasing co-use of stimulants and opioids from online drug forum data

This study examines stimulant co-mention trends among PWUO/PTMOUD on social media over multiple years.

Original research | 2022

About PWUD, Illegal drugs, Stimulants

Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study

People who use methamphetamine concurrently with opioids face an elevated risk of harm.

Original research | 2022

Harm reduction, About PWUD, Equity, Stimulants

Parlons-en! Le matériel de réduction des méfaits comme outil d’interaction

Manuel | 2020

la réduction des méfaits, les services enveloppants, à propos des prescripteurs, les services sociaux, les drogues illégales, les stimulants, s'injecter les drogues

Will hope triumph over experience in pharmacotherapy research on cocaine use disorder?

Commentary | 2020

Stimulants, About prescribers, Illegal drugs

Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study

We aimed to determine whether the risk of psychotic events increases immediately after initiation of methylphenidate treatment or, in the longer term, 1 year after treatment initiation in adolescen

Original research | 2019

Stimulants, Youth, Mental health, Transitions in care/treatment, About prescribers, Outcomes

Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis

We conducted a systematic review and meta-analysis to evaluate usefulness of an agonist approach as treatment of (psycho)stimulant use disorder (PSUD).

Lit review | 2020

About prescribers, Outcomes, Evidence base, Illegal drugs, Stimulants

Factors Associated with Perceived Decline in the Quality of Drugs During the COVID-19 pandemic: Evidence from Community-Recruited Cohorts of People Who Use Drugs in Vancouver, Canada

This study aimed to characterize the prevalence of and the factors associated with a perceived decline in the quality of drugs during the COVID-19 pandemic among community-recruited cohorts of PWUD

Original research | 2022

Overdose, Safer supply, About PWUD, Illegal drugs, Stimulants

Methamphetamine/amphetamine use over time among persons with opioid use disorders treated with buprenorphine/naloxone versus extended-release naltrexone

The study aims were to describe methamphetamine/amphetamine (MA/A) use among patients treated for OUD with buprenorphine/naloxone (BUP-NX) or extended-release naltrexone (XR-NTX), and to explore as

Original research | 2022

Stimulants, About PWUD, Illegal drugs

The Current State of Psychostimulants Use and Harms in Canada

Original research | 2022

Safer supply, Policy/Regulatory, Stimulants, Illegal drugs

Evidence synthesis – Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence

The objective of this review was to synthesize current knowledge of the reasons for combining substances in a single defined episode of drug use.

Lit review | 2022

About PWUD, Illegal drugs, Stimulants

Polysubstance use poisoning deaths in Canada: an analysis of trends from 2014 to 2017 using mortality dataa

Current evidence suggests that the non-medical use of synthetic opioids, stimulants and patterns of polysubstance use are major factors contributing to the increase in drug poisoning deaths in Cana

Original research | 2022

Mortality, About PWUD, Stimulants

Association Between Law Enforcement Seizures of Illicit Drugs and Drug Overdose Deaths Involving Cocaine and Methamphetamine, Ohio, 2014–2019

Law enforcement drug seizure data present a unique opportunity to examine the association between illicit-stimulant-involved overdose deaths (ISODs) and the illicit drug supply.

Original research | 2022

Overdose, Mortality, About PWUD, Legal system/law enforcement, Illegal drugs, Stimulants

Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005-2019

There is evidence of change in recent substance type associated with morbidity and mortality.

Original research | 2022

Overdose, Mortality, Harm reduction, About PWUD, Illegal drugs, Stimulants

Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial

Heroin-assisted treatment is eff ective for methadone treatment-refractory heroin-dependent patients, but continued comorbid cocaine dependence remains problematic.

Original research | 2016

Safer supply, About PWUD, Outcomes, Illegal drugs, Stimulants